1. Medtech Insight

Minute Insight: Phage-Based TB Diagnostic Demonstrates Capability

 
• By Barnaby Pickering

Actiphage, developed by PBD Biotech could be a key tool in the fight against tuberculosis.  

Minute Insight
• Source: Informa/Alamy

PBD Biotech, a Suffolk, UK-based diagnostics company, is trying to relieve the burden of tuberculosis diagnosis with its phage-based test, Actiphage.

According to the World Health Organization, tuberculosis is currently the 13th leading cause of death, and the second most infectious cause of death, after COVID-19. Multiple drug-resistant strains have emerged,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.